101. COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer
- Author
-
Guangyuan Song, Muhammad Ibrahim Alhadi Edoo, Lin Zhou, Shusen Zheng, Donghai Jiang, Kwabena Gyabaah Owusu‑Ansah, Haiyang Xie, Ronggao Chen, Jian Wu, Bingjie Chen, and Jun Li
- Subjects
0301 basic medicine ,Oncology ,Male ,Cancer Research ,medicine.medical_specialty ,Epithelial-Mesenchymal Transition ,Cell ,pancreatic cancer ,COL6A1 ,Collagen Type VI ,Biology ,Adenocarcinoma ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,Cell Movement ,Pancreatic cancer ,Internal medicine ,medicine ,Biomarkers, Tumor ,Tumor Cells, Cultured ,Humans ,metastasis ,Neoplasm Invasiveness ,Cell Proliferation ,Oncogene ,Hazard ratio ,Cancer ,Articles ,Cell cycle ,Middle Aged ,medicine.disease ,Prognosis ,Molecular medicine ,prognostic predictor ,Gene Expression Regulation, Neoplastic ,Pancreatic Neoplasms ,Survival Rate ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Lymphatic Metastasis ,Female ,Follow-Up Studies - Abstract
Pancreatic cancer is one of the most aggressive cancers worldwide with a high mortality rate. Prognosis remains poor even in this era of advanced medicine mainly due to early metastasis and invasion. The present study aimed to explore and validate predictors of distant metastasis and prognosis in pancreatic cancer. In our preliminary experiment, we established a novel metastatic pancreatic cancer cell line BxPC-M8 from parent BxPC-3 cells. Via whole genome sequencing, RT-qPCR, western blotting, migration and invasion assays, we initially found that BxPC-M8 shared similar biological characteristics to BxPC-3, but only differed in enhanced metastatic and invasive capabilities with a significant increase in collagen type VI α1 chain (COL6A1) expression. Knockdown of COL6A1 via small interfering RNA led to a significant decrease in migration and invasion of BxPC-M8 cells, suggesting suppressed epithelial-mesenchymal transition. Furthermore, a significant increase in COL6A1 expression was observed in cancerous tissue compared with paracancerous tissue (40.7 vs 3.7, P=0.001). Additionally, its expression was observed to be significantly associated with distant metastasis and vascular invasion at the time of surgery. Multivariate analysis revealed that COL6A1 expression (hazard ratio 1.90, 95% confidence interval 1.04-3.47, P=0.037) is an independent predictor of overall survival (OS). The median OS observed for COL6A1+ and COL6A1− patients was found to be 8±4 and 14±7 months (P=0.021), respectively. Of note, we identified that COL6A1 expression in tissue samples was associated with significantly reduced OS (P=0.001), demonstrating that COL6A1 may serve an important role in the metastatic process and could be considered as a predictor of poor outcomes in patients with pancreatic cancer. In addition, our findings suggest that COL6A1 could be an indicator of distant metastasis and a valid prognostic predictor in such patients; however, further investigation is required.
- Published
- 2019